Propanc Biopharma, Inc. (PPCB): Capital Expenditures

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Capital Expenditures is for the year ended 2019-06-30, while the company's latest annual report covers the year ended 2025-06-30. Its later filings do not report this line under the concept TickerFacts maps.

$2.9K
Year ended 2019-06-30
-33.7%
3-year compound annual growth
$9.9K2011-06-30: $3.5K2014-06-30: $02015-06-30: $3.9K2016-06-30: $9.9K2019-06-30: $2.9K$2.9K
2011-06-30 Capital Expenditures (USD) 2019-06-30
Period endedCapital ExpendituresChange YoYSource filing
2019-06-30$2.9Kn/a2020-10-01, From 2018-07-01
No annual figure between 2016-06-30 and 2019-06-30.
2016-06-30$9.9K+153.2%2017-09-28, From 2015-07-01
2015-06-30$3.9Kn/a2016-09-28, From 2014-07-01
2014-06-30$0n/a2015-09-30, From 2013-07-01
No annual figure between 2011-06-30 and 2014-06-30.
2011-06-30$3.5Kn/a2012-10-15, From 2010-07-01